Fig. 2From: Impact of Treviamet® & Treviamet XR® on quality of life besides glycemic control in type 2 DM patients(a): HbA1c from baseline to the last follow-up visit; (b): Fasting Plasma Glucose from baseline to the last follow-up visit; (c): Quality of Life from baseline to the last follow-up visitBack to article page